ArticleJACC. Case reports2025
Left Ventricular Mesenchymal Hamartoma: Exploring Diagnostic Approaches and Potential Therapeutic Strategies.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary malignant cardiac tumor of the left atrium masqueraded as multiple myxomas.Quantitative imaging in medicine and surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac hamartomas are rare benign tumors of disorganized native cardiac tissue that can cause obstruction, arrhythmias, or heart failure, despite their nonmetastatic nature. A 43-year-old woman with intermittent chest tightness and dyspnea underwent imaging suggestive of a malignant cardiac tumor. Intraoperative findings revealed a left ventricular basal inferoseptal hamartoma. Complete surgical resection was deemed too risky due to its location. Instead, transcatheter arterial embolization was performed to reduce the tumor's blood supply, and follow-up imaging showed regression. After ruling out malignancy, balancing the benefits of full surgical removal against the potential impact on cardiac function is crucial. In selected benign cases, transcatheter arterial embolization can be an effective, minimally invasive approach to control tumor growth and preserve heart function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.